The Agency for Healthcare Research and Quality and the National Council on Patient Information and Education today announced a new resource called Your Medicine: Play It Safe, to help consumers use prescription medicines safely. The 12-page brochure, available in English and Spanish, includes a detachable, pocket-sized medicine record form that can be personalized.
Cannabis-based drugs could be prescribed in the United Kingdom as early as 2003 following word from a British pharmaceutical company that four Phase III clinical trials showed the drugs successfully treated symptoms associated with multiple sclerosis and neuropathic pain. In the trials, the pot-based medicine achieved statistically significant reductions in neuropathic (nerve-damage) pain, as well as statistically significant improvements in other symptoms of MS, most notably spasticity and sleep disturbance.